Austco Healthcare Limited (AU:AHC)
ASX:AHC
Want to see AU:AHC full AI Analyst Report?
Top Page
Austco Healthcare Limited
(Sydney:AHC)
Select Model
Select Model
Rating:63Neutral
Price Target:
AU$0.41
▲(20.59% Upside)
Action:ReiteratedDate:02/07/26
Overall score reflects strong financial health led by low leverage and solid revenue growth, partially offset by margin compression and slowing free cash flow growth. Technical indicators are a notable drag due to a clear downtrend (price below key moving averages, negative MACD). Valuation is neither compellingly cheap nor clearly expensive based on the provided P/E, with no dividend yield data to add support.
Positive Factors
Recurring revenue model
AHC's mix of product sales plus project services and ongoing support/subscriptions creates recurring revenue and customer stickiness. That business model smooths cash flows, supports higher lifetime customer value, and enables predictable maintenance and software upsell streams over the medium term.
Negative Factors
Margin compression
A sharp decline in net margin erodes the company's ability to convert revenue into reinvestable cash. If higher costs or pricing pressure persist, profitability headwinds could limit funding for product development, sales expansion, and long‑term margin recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue model
AHC's mix of product sales plus project services and ongoing support/subscriptions creates recurring revenue and customer stickiness. That business model smooths cash flows, supports higher lifetime customer value, and enables predictable maintenance and software upsell streams over the medium term.
Read all positive factors
Austco Healthcare Limited (AHC) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$123.67M
Dividend YieldN/A
Average Volume (3M)242.22K
Price to Earnings (P/E)7.7
Beta (1Y)0.75
Revenue Growth28.40%
EPS Growth-22.71%
CountryAU
Employees102
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)0.01
Shares Outstanding374,751,280
10 Day Avg. Volume336,746
30 Day Avg. Volume242,221
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)2.08
Price to Sales (P/S)1.32
P/FCF Ratio10.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.55Price Target Upside61.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)AU$105.70M
Austco Healthcare Limited Business Overview & Revenue Model
Company Description
Austco Healthcare Limited, together with its subsidiaries, engages in the manufacture, distribution, marketing, supply, service, and sale of healthcare and electronic communications systems in Australia, New Zealand, Asia, Europe, and North Americ...
How the Company Makes Money
AHC makes money primarily by selling and deploying clinical communication and nurse call systems to healthcare providers. Revenue is generated from (1) product and system sales (including hardware and software components delivered as part of a sit...
Austco Healthcare Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.73M | 81.41M | 58.15M | 41.98M | 35.88M | 31.25M |
| Gross Profit | 34.91M | 42.37M | 30.67M | 6.68M | 18.85M | 16.71M |
| EBITDA | 13.87M | 11.10M | 8.11M | 3.60M | 3.73M | 5.01M |
| Net Income | 7.75M | 5.93M | 7.08M | 2.26M | 2.33M | 3.42M |
Balance Sheet | ||||||
| Total Assets | 87.50M | 91.07M | 68.70M | 37.85M | 34.03M | 27.18M |
| Cash, Cash Equivalents and Short-Term Investments | 15.23M | 14.48M | 13.56M | 4.67M | 7.63M | 7.77M |
| Total Debt | 7.68M | 3.88M | 1.78M | 524.00K | 979.00K | 1.15M |
| Total Liabilities | 28.76M | 39.34M | 24.33M | 12.85M | 10.94M | 7.88M |
| Stockholders Equity | 58.76M | 51.73M | 44.38M | 25.00M | 23.09M | 19.30M |
Cash Flow | ||||||
| Free Cash Flow | 17.39M | 10.66M | 7.45M | -1.25M | 315.00K | 1.91M |
| Operating Cash Flow | 20.36M | 13.42M | 11.35M | 320.00K | 1.94M | 3.21M |
| Investing Cash Flow | -14.00M | -12.32M | -11.06M | -1.57M | -1.63M | -1.30M |
| Financing Cash Flow | -1.08M | -402.00K | 8.84M | -1.58M | -312.00K | -474.00K |
Austco Healthcare Limited Technical Analysis
Negative
0.34
Price Trends
0.35
Negative
0.37
Negative
0.38
Negative
Market Momentum
>-0.01
Negative
45.06
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHC, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.35, and below the 200-day MA of 0.38, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.06 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHC.
Austco Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | AU$123.67M | 7.70 | 14.03% | ― | 28.40% | -22.71% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | AU$57.99M | -59.43 | -1.32% | ― | 6.20% | 95.19% | |
46 Neutral | AU$96.70M | -14.80 | -40.65% | ― | -100.00% | -11.11% | |
44 Neutral | AU$93.29M | -6.27 | -54.48% | ― | 17.24% | -20.00% | |
43 Neutral | AU$66.35M | -6.64 | -59.96% | ― | ― | ― | |
41 Neutral | AU$2.50B | -3.16 | -890.76% | ― | -0.80% | -249.48% |
* Healthcare Sector Average
AU:AHC
Austco Healthcare Limited
0.33
0.05
17.86%
AU:CYC
Cyclopharm Limited
0.74
-0.43
-36.75%
AU:SHG
Singular Health Group Ltd
0.21
-0.08
-28.81%
AU:TRJ
Trajan Group Holdings Ltd
0.38
-0.43
-53.09%
AU:4DX
4DMedical Ltd
4.24
3.92
1225.00%
AU:ALA
Arovella Therapeutics Limited
0.08
>-0.01
-6.98%
Austco Healthcare Limited Corporate Events
Austco Director Shifts Shareholdings to Indirect Holding Structure
Mar 3, 2026
Austco Healthcare has disclosed a change in the shareholdings of director James Brett Francis Burns, reflecting an internal rebalancing of his direct and indirect interests. Burns disposed of his directly held shares while increasing his indirect ...
Austco Healthcare Cancels 393,946 Performance Rights After Conditions Not Met
Jan 6, 2026
Austco Healthcare Limited has announced the cessation of 393,946 performance rights, which lapsed on 5 January 2026 because the conditions attached to these rights were not met or became incapable of being satisfied. The lapse of these conditional...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.